Alcon AG | ALC - Ativo Circulante





Ativo Circulante Alterar Data
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Essilor EUR 12.01B 981M 2025-12
Fresenius EUR 11.03B 1.03B 2025-12
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Lonza CHF 8B 3.41B 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Philips EUR 9.78B 148M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Smith & Nephew USD 4.63B 169M 2025-12
Sonova Holding CHF 1.91B 466.3M 2025-06
UCB EUR 6.05B 733M 2025-12